Cagrilintide is a synthetic research compound designed to act on amylin receptors, which are involved in appetite, feelings of fullness, and metabolic signaling. It is a long-acting analog of amylin, a naturally occurring hormone released alongside insulin after food intake.
Research has explored its relationship with appetite signaling, satiety, food intake, body weight, and metabolic regulation. Scientists are particularly interested in how amylin-related pathways communicate between the digestive system and brain to help regulate energy balance and eating behavior.
Ophir Health Cagrilintide provides a precisely measured format for laboratory research involving amylin receptor activity, appetite and satiety pathways, metabolic signaling, and body-weight research.
